Antonina Trzaskoma

Antonina Trzaskoma

Auto-generated profile, based on publicly available information

Antonina Trzaskoma


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 June 2026 in Quality in Sport
Verified
Journal Article
Open access
PDF file
MCMateusz Chmiela
Mateusz Chmiela
WBWojciech Przemysław Baran
Wojciech Przemysław Baran
PBPatrycja Anna Bartkiewicz
Patrycja Anna Bartkiewicz
AŚAda Świątko
Ada Świątko
TJTomasz Wiktor Jędrasek
Tomasz Wiktor Jędrasek
ATAntonina Trzaskoma
Antonina Trzaskoma
Introduction: In recent years, bigorexia has gained increasing attention as a mental health issue closely linked to the rise of contemporary fitness culture promoting extreme muscularity, reduced body fat, and appearance-oriented lifestyles. The condition involves a distorted perception of one’s physique, accompanied by a persistent belief of being inadequately muscular despite often having a well-developed body. Aim: This review aimed to summarize and critically discuss current findings on bigorexia, focusing on its epidemiology, contributing risk factors, symptomatology, diagnostic challenges, and available treatment strategies. Review findings: Bigorexia predominantly affects individuals participating in bodybuilding and other strength-focused activities, especially men, although emerging evidence suggests that women may also be affected more frequently than previously recognized. The disorder is frequently overlooked in clinical practice, partly because its symptoms overlap with other psychiatric conditions such as depressive disorders, anxiety disorders, eating disorders, and occasionally psychotic spectrum disorders. Accurate differential diagnosis is therefore crucial. Although evidence regarding treatment remains limited, psychotherapy constitutes the cornerstone of management, with cognitive-behavioral therapy demonstrating the greatest effectiveness. In some patients, pharmacological support may additionally be considered. Conclusions: Greater awareness of bigorexia among clinicians and society is necessary to facilitate earlier identification and more effective intervention. Additional research is needed to better define the disorder, clarify gender-related differences, and develop evidence-based therapeutic approaches.

17 July 2026 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
PBPatrycja Anna Bartkiewicz
Patrycja Anna Bartkiewicz
WBWojciech Przemysław Baran
Wojciech Przemysław Baran
AŚAda Świątko
Ada Świątko
TJTomasz Wiktor Jędrasek
Tomasz Wiktor Jędrasek
ELEwelina Lachowska
Ewelina Lachowska
MCMateusz Chmiela
Mateusz Chmiela
Introduction: Hypercholesterolemia is a leading cardiovascular risk factor with a global prevalence of approximately 24%, contributing substantially to atherosclerotic disease. Despite the well-established efficacy of statins and other pharmacological agents, adherence remains a challenge due to adverse effects and patient reluctance toward conventional therapy. Purpose: This narrative review synthesizes current evidence on the lipid-modulating properties of seven herbal products and nutraceuticals: garlic, green tea, guggul, red yeast rice, fenugreek, artichoke, and berberine. It focuses on their mechanisms of action, clinical efficacy, and safety profiles. Current knowledge: The reviewed compounds exhibit diverse lipid-lowering mechanisms, including HMG-CoA reductase inhibition, LDL receptor upregulation, reduced intestinal cholesterol absorption, and enhanced bile acid excretion. Red yeast rice, owing to its lovastatin content, holds the strongest clinical evidence, achieving LDL-C reductions of 15-34%. Berberine and artichoke leaf extract also show consistent lipid-lowering effects. Evidence for garlic, green tea, and fenugreek is promising but heterogeneous. Guggul data remain conflicting, with some trials reporting adverse lipid outcomes. Conclusions: These nutraceuticals may serve as adjunctive interventions alongside lifestyle modification in selected patients but cannot replace established pharmacotherapy. Large-scale, standardized randomized controlled trials are needed to confirm their efficacy and long-term safety.